Cardiol Therapeutics Inc. Basic Earnings Loss Per Share
Cardiol Therapeutics Inc. (CRDL) reported Basic Earnings Loss Per Share of -0.39 CAD/shares for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShare · last filed 2026-03-31
| Period end | Basic Earnings Loss Per Share 12 month |
|---|---|
| 2025-12-31 | -0.39 CAD/shares 40-F · filed 2026-03-31 |
| 2024-12-31 | -0.51 CAD/shares 40-F · filed 2026-03-31 |
| 2023-12-31 | -0.44 CAD/shares 40-F · filed 2025-03-31 |
| 2022-12-31 | -0.49 CAD/shares 20-F · filed 2024-04-01 |
| 2021-12-31 | -0.73 CAD/shares 20-F · filed 2024-04-01 |
| 2020-12-31 | -0.69 CAD/shares 20-F · filed 2023-03-29 |